These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18853658)

  • 1. [Diabetes control in type 2 diabetic subjects treated in primary health care--how far is from life to standards?].
    Fabian W; Majkowska L; Stefański A; Moleda P
    Przegl Lek; 2008; 65(6):277-82. PubMed ID: 18853658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diabetes control in type 2 diabetic subjects treated in primary health care].
    Fabian W; Majkowska L; Moleda P; Stefański A
    Pol Arch Med Wewn; 2006 Aug; 116(2):760-5. PubMed ID: 17424921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and treatment goals in Polish patients with type 2 diabetes of short duration: results of the ARETAEUS2-Grupa study.
    Bała MM; Płaczkiewicz-Jankowska E; Leśniak W; Topór-Mądry R; Michałejko M; Jankowski M; Strzeszyński L; Sieradzki J; Czupryniak L;
    Pol Arch Med Wewn; 2013; 123(11):573-81. PubMed ID: 24241157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care delivery in type 2 diabetes. A survey in an Italian primary care practice.
    Modesti A; Bartaloni R; Bellagamba F; Caglieri R; Cenori K; Ciampalini G; Costagli A; Galloni V; Del Papa C; Modesti L; Dell'Omo G; Pedrinelli R
    Prim Care Diabetes; 2015 Feb; 9(1):9-14. PubMed ID: 24908631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Appearance of undiagnosed diabetes mellitus in the population of professionally active people in the urban areas].
    Wierusz-Wysocka B; Zozulińska D; Knast B; Pisarczyk-Wiza D
    Pol Arch Med Wewn; 2001 Sep; 106(3):815-21. PubMed ID: 11928591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of factors predicting early evolution of secondary oral hypoglycaemic agent failure and evaluation of clinical standards applied by primary care physicians during qualification to insulin therapy of patients with type 2 diabetes].
    Machoy M
    Ann Acad Med Stetin; 2004; 50(2):29-39. PubMed ID: 16529163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Diabetes Education in Adults With Diabetes Mellitus Type 2 in Primary Care: A Systematic Review.
    Cruz-Cobo C; Santi-Cano MJ
    J Nurs Scholarsh; 2020 Mar; 52(2):155-163. PubMed ID: 31912967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are general practitioners characteristics associated with the quality of type 2 diabetes care in general practice? Results from the Norwegian ROSA4 study from 2014.
    Tran AT; Bakke Å; Berg TJ; Gjelsvik B; Mdala I; Nøkleby K; Shakil Rai A; Cooper JG; Claudi T; Løvaas K; Thue G; Sandberg S; Jenum AK
    Scand J Prim Health Care; 2018 Jun; 36(2):170-179. PubMed ID: 29717939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reductions in diabetic cardiovascular risk by community primary care providers.
    Reed HL; Bernard E
    Int J Circumpolar Health; 2005 Feb; 64(1):26-37. PubMed ID: 15776990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.
    Corcillo A; Pivin E; Lalubin F; Pitteloud N; Burnier M; Zanchi A
    Swiss Med Wkly; 2017; 147():w14459. PubMed ID: 28695552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of type II diabetes mellitus in population of Krakow].
    Szurkowska M; Szybiński Z; Nazim A; Szafraniec K; Jedrychowski W
    Pol Arch Med Wewn; 2001 Sep; 106(3):771-9. PubMed ID: 11928585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin for the management of Type 2 diabetic patients with dyslipidaemia. A mid-term (9 months) treatment experience.
    Velussi M; Cernigoi AM; Tortul C; Merni M
    Diabetes Nutr Metab; 1999 Dec; 12(6):407-12. PubMed ID: 10782562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study on Glycaemic Status and Lipid Profile in Type 2 Diabetic Patients Attending Mymensingh Medical College Hospital, Mymensingh.
    Tabazzum R; Mia AR; Haq RU; Epsi EZ
    Mymensingh Med J; 2016 Jul; 25(3):438-44. PubMed ID: 27612888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines.
    Sliz D; Mamcarz A; Filipiak KJ; Siebert J; Naruszewicz M
    Pol Arch Med Wewn; 2010 Sep; 120(9):328-33. PubMed ID: 20864905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of patients with type 2 diabetes of short duration in Poland: Rationale, design and preliminary results of the ARETAEUS1 study.
    Bała MM; Płaczkiewicz-Jankowska E; Topór-Madry R; Leśniak W; Wiercińska E; Szczepaniak P; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
    Pol Arch Med Wewn; 2009 Sep; 119(9):533-40. PubMed ID: 19776697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex and age differences in the achievement of control targets in patients with type 2 diabetes: results from a population-based study in a South European region.
    Cambra K; Galbete A; Forga L; Lecea O; Ariz MJ; Moreno-Iribas C; Aizpuru F; Ibañez B
    BMC Fam Pract; 2016 Oct; 17(1):144. PubMed ID: 27729015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines?
    George PB; Tobin KJ; Corpus RA; Devlin WH; O'Neill WW
    Am Heart J; 2001 Nov; 142(5):857-63. PubMed ID: 11685175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Achieving target levels for vascular risk parameters in Polish school-age children with type 1 diabetes - a single center study.
    Szadkowska A; Michalak A; Chylińska-Frątczak A; Baranowska-Jaźwiecka A; Koptas M; Pietrzak I; Hogendorf A; Zmysłowska A; Młynarski W; Mianowska B
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1073-1079. PubMed ID: 30240358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of Medical Nutritional Therapy in the Management of Type 2 Diabetes Mellitus.
    Varadaraj G; Sangeetha B; Nithiya DR; Dixit PK
    J Assoc Physicians India; 2021 Apr; 69(4):11-12. PubMed ID: 34470186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.